Companies Dominating the Biocatalysis & Biocatalysts Market Landscape
- DuPont de Nemours, Inc.
- Business strategy
- Key product offerings
- Financial performance
- Risk analysis
- Recent development
- Regional presence
- SWOT Analysis
- BASF SE
- Novozymes A/S
- Lonza Group Ltd.
- Royal DSM Lockheed Martin
- Codexis, Inc.
- AB Enzymes
- Sapporo Enzyme Co., Ltd.
- Dyadic International, Inc.
- Soufflet Group
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of biocatalysis & biocatalysts is evaluated at USD 722.52 million.
The biocatalysis & biocatalysts market size was valued at USD 669.04 million in 2024 and is expected to reach USD 1.24 billion by 2037, expanding at around 4.9% CAGR during the forecast period i.e., between 2025-2037. Increased demand for the medicines used to manufacture pharmaceuticals will drive the market growth.
North America industry is anticipated to hold largest revenue share of 34% by 2037, as use of biocatalysts to produce biochemicals, biofuels, and other biomaterial have been playing a significant role in waste reduction which is making them very effective for use in the chemical sector in the region.
The major players in the market are DuPont de Nemours, Inc., BASF SE, Novozymes A/S, Lonza Group Ltd., Royal DSM Lockheed Martin, Codexis, Inc., AB Enzymes, Sapporo Enzyme Co., Ltd., Dyadic International, Inc., Soufflet Group
